IPO | China Hong Kong Holdings IPO from today, expected to be listed on July 12

Futu Press Release June 28, This Week 2$ Zhongkang Holdings (02361.HK) $The announcement was made that a public offering of 750 million shares will be issued from 28 June to 5 July, including a public offering of 750 million shares, an international offering of 6750 million shares at an issue price of HK$5.36-6.96 per share, 500 shares per share, and is expected to be listed on 12 July.

CITIC HOLDINGS PRIMARILY PROVIDES HEALTH INSIGHT SOLUTIONS TO ADDRESS THE SALES AND MARKETING NEEDS OF MEDICAL PRODUCT MANUFACTURER CUSTOMERS. These solutions are mainly based on the company's retail data, while retail data makes up the bulk of the company's healthy big data.

Since 2008, the company has been committed to driving the digital transformation of China's health industry. Driven by big data and technology, the company has been developing comprehensive health big data solutions for health industry participants, primarily providing market-driven end-to-end solutions for the sales and marketing functions of medical product manufacturer customers. and products.

The company is a leader in the medical products and channels division. According to Airi Consulting, the number of top medical product manufacturers served in 2020 (based on Torreya and the 2020 list of top medical product manufacturers based on Torreya and Pharma Network's 2020 list of top medical product manufacturers) and enterprise-class customer numbers for China Health Insights Solutions, according to an Airi Consulting report, based on the number of top medical product manufacturers and enterprise-class customers Words ranked first.

In terms of financial condition, the Company's revenue in 2019—2021 was RMB 1.78, 2.02 yuan and RMB 3.24, with a compound growth rate of 34.92% over the three years, and net profit was HK$5437.9 million, RMB6532.9 million and RMB7197.8 million, respectively. The net interest rate was 30.6%, 32.3% and 22.2%, respectively.

In terms of industry, according to data from Airi Consulting, the Chinese Health Insights Solutions market will grow at 39.2% in the combined year from 2021 to 2026, and the market size will reach RMB 1,303 by 2026.

From 2021 to 2026, the combined growth rate of China's medical products and channel insight solutions market will be 49.4%, and the market size will now reach RMB611.

As far as investors are concerned, the Company has entered into an investment agreement with Ocean Health Limited, Lun's Family, Kang Shi One Limited and Mr. Zheng. Foundation Investors have agreed to purchase a total of HK$1.3 (excluding brokerage commissions, securities commission fees, fees, finance, etc.) under certain conditions Exchange transaction fees and Exchange transaction fees) Offer of a relevant number of shares purchased.

In terms of capital use, the company will receive net proceeds from global sales for the following purposes, of which approximately 50.8% will be used primarily to upgrade and enhance the company's SaaS products (focused on smart decision cloud, smart retail cloud and smart healthcare) and their marketing and promotion; approximately 49.2% will be used primarily for the company's Advanced research and development of the technology and data repository, particularly in relation to the following projects: the company's artificial intelligence technology, including big data and artificial intelligence laboratories, the company's Apaas cognitive medical platform, ApaAs, and the life science solution APaaS; and The centerpiece of Sinohealth Engine.

41K Views